FIELD: organic chemistry, chemical technology, medicine, pharmacy. SUBSTANCE: invention relates to crystalline derivative of dibenzothiazepine of the formula (I) with melting point from 83 to 86 C. Invention describes also methods for preparing and purification of this compound and pharmaceutical composition eliciting anti-dopaminergic effect used for treatment of psychosis and based on this compound. Invention provides preparing a novel form of compound. EFFECT: improved preparing method, valuable medicinal property of compound. 22 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION, METHOD FOR ITS OBTAINING, METHOD FOR TREATING PSYCHOTIC STATES AND HYPERACTIVITY | 1997 |
|
RU2201754C2 |
QUETIAPINE GRANULATED COMPOSITION | 2000 |
|
RU2256453C2 |
METHOD FOR PREPARING QUETIAPINE AND INTERMEDIATE COMPOUNDS | 2001 |
|
RU2258067C2 |
METHOD FOR PREPARING DERIVATIVES OF DIBENZOTHIAZEPINE | 1999 |
|
RU2233275C2 |
AMINOSUBSTITUTED DIARYL [a, d] CYCLOHEPTANE ANALOGUES AS MUSCARINIC AGONISTS AND METHOD OF TREATING PSYCHONEUROLOGICAL DISORDERS | 2004 |
|
RU2394030C2 |
CONJUGATES AND SMALL MOLECULES, INTERACTING WITH CD16a RECEPTOR | 2013 |
|
RU2519546C1 |
DIBENZO[b,f][1, 4]OXAZAPINE COMPOUNDS | 2008 |
|
RU2469033C2 |
SUBSTITUTED TETRACYCLIC DERIVATIVES OF OXAZEPINE AND THIAZEPINE, METHOD OF THEIR SYNTHESIS, COMPOSITION WITH ANTIPSYCHOTIC ACTIVITY AND METHOD OF ITS PREPARING | 1995 |
|
RU2161159C2 |
0 |
|
SU475777A3 | |
0 |
|
SU457220A3 |
Authors
Dates
2004-02-27—Published
1998-07-28—Filed